John Whyte, MD
This article was originally published in The Gray Sheet
CMS medical officer begins detail at HHS Secretary's Council on Private Sector Initiatives to Improve the Security, Safety, and Quality of Health Care (CPSI), where he will initially deal with bioterrorism issues. The council triages requests from private sector individuals and firms seeking review of their ideas or products and forwards the information to the appropriate agencies and offices within HHS...
You may also be interested in...
Becton Dickinson will spend $1.2bn over the next four years to improve its drug-delivery device manufacturing capabilities. See what Eric Borin, president of BD, said about it here.
Pfizer is producing vaccine doses at scale now that it has buttoned down the manufacturing process.
In second letter this year targeting email communications, OPDP says that putting the methotrexate oral solution’s risk information below the signature block does not offer ‘prominence and readability’ comparable to the information on the drug’s effectiveness for the treatment of acute lymphoblastic leukemia that was in the body of the email.